trihexyphenidyl has been researched along with Abnormal Movements in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "LTG, amantadine, and VPA were withdrawn, the remaining 2 drugs, benzhexol and compound preparation (flupentixol and melitracen), were continued to use, and the patient improved in 2." | 1.46 | Disabling tremor induced by long-term use of sodium valproate and lamotrigine: Case report. ( Chen, J; He, ZF; Rao, Z; Wang, XH; Zhou, CN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, ZF | 1 |
| Chen, J | 1 |
| Zhou, CN | 1 |
| Rao, Z | 1 |
| Wang, XH | 1 |
1 other study available for trihexyphenidyl and Abnormal Movements
| Article | Year |
|---|---|
Disabling tremor induced by long-term use of sodium valproate and lamotrigine: Case report.
Topics: Amantadine; Anticonvulsants; Antiparkinson Agents; Dyskinesia, Drug-Induced; Dyskinesias; Humans; La | 2017 |